A Study of Safety and Efficacy of PET-adapted Treatment With Nivolumab at the Fixed Dose 40 mg, Ifosfamide, Carboplatin, Etoposide (NICE-40) in Patients With Relapsed/Refractory Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Carboplatin
Related studies linked through entity extraction aliases.
First-line Treatment With Camrelizumab + Apatinib Versus Chemotherapy + Bevacizumab in Advanced Cervical Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Bintrafusp Alfa With Chemotherapy for Tyrosine Kinase Inhibitor-Resistant EGFR-Mutant Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Using ctDNA to Determine Therapies for Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Pembro+Chemo in Brain Mets
- Status
- TERMINATED
- Phase
- PHASE2
Comparing Efficacy and Safety Between Pertuzumab® and Perjeta® in Neoadjuvant Treatment of HER2+ Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Study of Pembrolizumab (MK-3475) Subcutaneous (SC) Versus Pembrolizumab Intravenous (IV) Administered With Platinum Doublet Chemotherapy in Participants With Metastatic Squamous or Nonsquamous Non-Small Cell Lung Cancer (NSCLC) (MK-3475-A86)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Trial With Chemotherapy, Immunotherapy, and Radiotherapy for Patients With Newly Diagnosed Stage IV Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Study of N9 Chemotherapy in Children With Neuroblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
Neoadjuvant Immunotherapy and Chemotherapy Followed by Surgery in Unresectable Stage Ⅲ NSCLC
- Status
- UNKNOWN
- Phase
- PHASE2
Oregovomab in Combination With Bevacizumab Plus Chemo in BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Chemoradiation and Pembrolizumab Followed by Pembrolizumab and Lenvatinib Before Surgery for the Treatment of Non-metastatic Esophageal or Esophageal/Gastroesophageal Junction Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Efficacy and Safety of Pembrolizumab Plus Investigational Agents in Combination With Chemotherapy as First-Line Treatment in Extensive-Stage Small Cell Lung Cancer (ES-SCLC) (MK-3475-B99/ KEYNOTE-B99)
- Status
- COMPLETED
- Phase
- PHASE2
Liver Directed RT + Chemo-immunotherapy for ES-SCLC
- Status
- TERMINATED
- Phase
- PHASE2
Study of Upifitamab Rilsodotin in Combination With Carboplatin in Participants With High-grade Serous Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Study of Camrelizumab Plus Chemotherapy as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC)
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Local Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 Therapy
- Status
- RECRUITING
- Phase
- PHASE2